Skip to main content
. 2017 Sep 16;8(46):81662–81678. doi: 10.18632/oncotarget.20953

Table 9. Clinical trials with cell cycle checkpoint inhibitors in HNSCC.

Class Compound Combination Phase State NCT number
CHK1/2 inhibitor LY2606368 / 1 Completed NCT01115790
Cisplatin, RT, Cetuximab 1 Recruiting NCT02555644
WEE1 inhibitor AZD1775 Cisplatin, RT 1 Recruiting NCT02585973
Cisplatin, RT 1 Not yet recruiting NCT03028766
Cisplatin, Docetaxel, Surgery 1 Recruiting NCT02508246
Cisplatin 2 Terminated NCT02196168

RT: Radiotherapy, NCT: Number clinicaltrials.gov identifier.